Cargando…

Elevated Monoamine Oxidase-A in Anterior Cingulate of Post-Mortem Human Parkinson’s Disease: A Potential Surrogate Biomarker for Lewy Bodies?

Lewy bodies (LB) play a neuropathological role in Parkinson’s disease (PD). Our goal was to evaluate LB using anti-ubiquitin immunohistochemistry (UIHC) and find correlations with monoamine oxidase-A (MAO-A) using imaging agent, [(18)F]FAZIN3. Human post-mortem anterior cingulate (AC) and corpus cal...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mukherjee, Jogeshwar, Ladwa, Reisha M., Liang, Christopher, Syed, Amina U.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9777299/ https://www.ncbi.nlm.nih.gov/pubmed/36552764 http://dx.doi.org/10.3390/cells11244000

Ejemplares similares

[(18)F]Nifene PET/CT Imaging in Mice: Improved Methods and Preliminary Studies of α4β2* Nicotinic Acetylcholinergic Receptors in Transgenic A53T Mouse Model of α-Synucleinopathy and Post-Mortem Human Parkinson’s Disease
por: Campoy, Anthony-David T., et al.
Publicado: (2021)

Comparison of Monoamine Oxidase-A, Aβ Plaques, Tau, and Translocator Protein Levels in Postmortem Human Alzheimer’s Disease Brain
por: Syed, Amina U., et al.
Publicado: (2023)

Monoamine Oxidase-A Occupancy by Moclobemide and Phenelzine: Implications for the Development of Monoamine Oxidase Inhibitors
por: Chiuccariello, Lina, et al.
Publicado: (2015)

ABUSE OF MONOAMINE OXIDASE INHIBITORS
por: Ananth, Jambur, et al.
Publicado: (1995)

Monoamine Oxidase-B Inhibitors for the Treatment of Parkinson’s Disease: Past, Present, and Future
por: Tan, Yu-Yan, et al.
Publicado: (2022)

Neuroprotective Function of Rasagiline and Selegiline, Inhibitors of Type B Monoamine Oxidase, and Role of Monoamine Oxidases in Synucleinopathies
por: Naoi, Makoto, et al.
Publicado: (2022)

Amphetamine Derivatives as Monoamine Oxidase Inhibitors
por: Reyes-Parada, Miguel, et al.
Publicado: (2020)

Parameters for Irreversible Inactivation of Monoamine Oxidase
por: Ramsay, Rona R., et al.
Publicado: (2020)

Efficacy, safety, and patient preference of monoamine oxidase B inhibitors in the treatment of Parkinson’s disease
por: Robottom, Bradley J
Publicado: (2011)

Monoamine oxidase-B (MAO-B) inhibitors: implications for disease-modification in Parkinson’s disease
por: Teo, Kay Cheong, et al.
Publicado: (2013)

Dopamine and vesicular monoamine transport loss supports incidental Lewy body disease as preclinical idiopathic Parkinson
por: Pifl, Christian, et al.
Publicado: (2023)

3-Coumaranone derivatives as inhibitors of monoamine oxidase
por: Van Dyk, Adriaan S, et al.
Publicado: (2015)

Monoamine Oxidase B in Renal Cell Carcinoma
por: Hodorová, Ingrid, et al.
Publicado: (2018)

Cardiac monoamine oxidases: at the heart of mitochondrial dysfunction
por: Mialet-Perez, Jeanne, et al.
Publicado: (2020)

Multiscale Modeling of Two-Photon Probes for Parkinson’s Diagnostics Based on Monoamine Oxidase B Biomarker
por: Murugan, N. Arul, et al.
Publicado: (2020)

Different Generations of Type-B Monoamine Oxidase Inhibitors in Parkinson’s Disease: From Bench to Bedside
por: Alborghetti, Marika, et al.
Publicado: (2019)

Three Dimensional Pharmacophore Modelling of Monoamine oxidase-A (MAO-A) inhibitors
por: Sairam, Kalapatapu V.V.M., et al.
Publicado: (2007)

[(125)I]INFT: Synthesis and Evaluation of a New Imaging Agent for Tau Protein in Post-Mortem Human Alzheimer’s Disease Brain
por: Limpengco, Roz R., et al.
Publicado: (2023)

Age-Related Behavioral Phenotype of an Astrocytic Monoamine Oxidase-B Transgenic Mouse Model of Parkinson’s Disease
por: Lieu, Christopher A., et al.
Publicado: (2013)

Monoamine-oxidase Type B Inhibitors and Cognitive Functions in Parkinson’s Disease: Beyond the Primary Mechanism of Action
por: Rinaldi, Domiziana, et al.
Publicado: (2023)

Smoking Related Diseases: The Central Role of Monoamine Oxidase
por: Rendu, Francine, et al.
Publicado: (2011)

Androgen receptor and monoamine oxidase polymorphism in wild bonobos
por: Garai, Cintia, et al.
Publicado: (2014)

Inhibition of Monoamine Oxidase by Stilbenes from Rheum palmatum
por: Wei, Bo, et al.
Publicado: (2016)

Mitochondrial Monoamine Oxidase: Another Player in Pulmonary Hypertension?
por: Sommer, Natascha, et al.
Publicado: (2021)

Recent advances on the role of monoamine oxidases in cardiac pathophysiology
por: Kaludercic, Nina, et al.
Publicado: (2023)

Cingulate island sign temporally changes in dementia with Lewy bodies
por: Iizuka, Tomomichi, et al.
Publicado: (2017)

Neuropathological Changes in Dementia With Lewy Bodies and the Cingulate Island Sign
por: Patterson, Lina, et al.
Publicado: (2019)

Lateralized ante mortem and post mortem pathology in a case of Lewy body disease with corticobasal syndrome
por: Coughlin, David G., et al.
Publicado: (2022)

Increased expression of pathological markers in Parkinson’s disease dementia post-mortem brains compared to dementia with Lewy bodies
por: Tu, Haitao, et al.
Publicado: (2022)

Effect of Alkaloids Isolated from Phyllodium pulchellum on Monoamine Levels and Monoamine Oxidase Activity in Rat Brain
por: Cai, Lu, et al.
Publicado: (2016)

Kynurenine pathway in post-mortem prefrontal cortex and cerebellum in schizophrenia: relationship with monoamines and symptomatology
por: Afia, Amira Ben, et al.
Publicado: (2021)

Methylxanthines Inhibit Primary Amine Oxidase and Monoamine Oxidase Activities of Human Adipose Tissue
por: Haj Ahmed, Wiem, et al.
Publicado: (2020)

Synaptic potentiation of anterior cingulate cortex contributes to chronic pain of Parkinson’s disease
por: Zhou, Zhaoxiang, et al.
Publicado: (2021)

Monoamine Oxidase and its Inhibition. CIBA Foundation Symposium 39
por: Bowers, Malcolm B.
Publicado: (1978)

2-acetylphenol analogs as potent reversible monoamine oxidase inhibitors
por: Legoabe, Lesetja J, et al.
Publicado: (2015)

An Adrenal Mass and Increased Catecholamines: Monoamine Oxidase or Pheochromocytoma Effect?
por: Bosscher, Marianne R. F., et al.
Publicado: (2015)

“Ping-pong gaze” secondary to monoamine oxidase inhibitor overdose
por: Attaway, Amy, et al.
Publicado: (2016)

Kinetics of Inhibition of Monoamine Oxidase Using Curcumin and Ellagic Acid
por: Khatri, Dharmendra Kumar, et al.
Publicado: (2016)

Regulatory Pathways of Monoamine Oxidase A during Social Stress
por: Higuchi, Yuki, et al.
Publicado: (2017)

Marine natural products with monoamine oxidase (MAO) inhibitory activity
por: Hong, Ahreum, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_gc113pqntjmfbqgb21fgboj3fn